Pediatric Cough/Cold Packaging No Place For Babies – Former NDAC Chair
This article was originally published in The Tan Sheet
Executive Summary
Firms may benefit from voluntarily removing references to infants from packaging for OTC pediatric cough/cold products, a pharmacy expert suggests as an FDA joint advisory panel prepares to discuss questions about the products' safety and efficacy
You may also be interested in...
Removing Pediatric OTC Cold Drugs Would Create New Problems – CHPA
Pulling pediatric cough/cold products off the shelf in an effort to curb adverse events could lead to "unintended" consequences, such as parents inappropriately giving children adult medication, according to results of a Consumer Healthcare Products Association study
Removing Pediatric OTC Cold Drugs Would Create New Problems – CHPA
Pulling pediatric cough/cold products off the shelf in an effort to curb adverse events could lead to "unintended" consequences, such as parents inappropriately giving children adult medication, according to results of a Consumer Healthcare Products Association study
Removing Pediatric OTC Cold Drugs Would Create New Problems – CHPA
Pulling pediatric cough/cold products off the shelf in an effort to curb adverse events could lead to "unintended" consequences, such as parents inappropriately giving children adult medication, according to results of a Consumer Healthcare Products Association study